We list hundreds of Clinical Trials about "Acute Allograft Rejection" on BioPortfolio. We draw our references from global clinical trials data listed on ClinicalTrials.gov and refresh our database daily.
More Information about "Acute Allograft Rejection" on BioPortfolio
We have published hundreds of Acute Allograft Rejection news stories on BioPortfolio along with dozens of Acute Allograft Rejection Clinical Trials and PubMed Articles about Acute Allograft Rejection for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Acute Allograft Rejection Companies in our database. You can also find out about relevant Acute Allograft Rejection Drugs and Medications on this site too.
This is 2-armed parallel group, prospective, randomized, open-label, multicenter Phase 3 controlled trial to establish the efficacy and safety of conversion from maintenance immunosuppressive therapy with Prograf® capsules (tacrolimus, Astellas Pharma US, Inc., Deerfield, IL) twice daily to maintenance immunotherapy with LCP Tacro™ tablets (tacrolimus, LifeCycle Pharma A/S, Hoersholm, Denmark) once daily for the prevention of acute allograft rejection in stable adult kidney...